acyclovir
Generic: acyclovir
Labeler: remedyrepack inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
remedyrepack inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70518-3436
Product ID
70518-3436_45260ec4-e5a4-78c9-e063-6294a90a593a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204313
Listing Expiration
2026-12-31
Marketing Start
2022-06-14
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
705183436
Hyphenated Format
70518-3436
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA204313 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 30 CAPSULE in 1 BLISTER PACK (70518-3436-0)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45260ec4-e5a4-78c9-e063-6294a90a593a", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["0990b625-5dfe-4810-b5b4-ac5948599e79"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (70518-3436-0)", "package_ndc": "70518-3436-0", "marketing_start_date": "20220614"}], "brand_name": "acyclovir", "product_id": "70518-3436_45260ec4-e5a4-78c9-e063-6294a90a593a", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-3436", "generic_name": "acyclovir", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20220614", "listing_expiration_date": "20261231"}